Prevention of gastrointestinal complications by infusion pump in patients receiving enteral nutritio
Not Applicable
Recruiting
- Conditions
- Inpatients receiving enteral nutrition via nasogastric tube, gastric fistula, or intestinal fistula
- Registration Number
- JPRN-UMIN000005609
- Lead Sponsor
- Division of Clinical pharmacokinetics, Faculty of Pharmacy, Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. CD toxin positive 2.Patient with diarrhea by antibiotic or other medicines such as laxative 3.Patient taking: The semisolid preparation, K2-S, K-LEC, enteral nutrition containing more than 1.7 g/100 kcal of dietary fiber or 1 kcal/mL of calories. 4.Patient with impaired gastrointestinal absorption due to diseases (short bowel syndrome and inflammatory bowel disease) 5.Patient with impaired gastrointestinal motility due to disease 6.Patient with aspiration pneumonia 7. Severely ill patient with multiple (>2) organ failure 8.Patient with severe diarrhea 9.Patient with fatty diarrhea 10.Patient with lactose intolerance 11.Patient not recommended to be registered by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method [BLOOD] labo data (on the registration, two weeks after, and at the end of the study) Blood chemistry: TP, ALB, BUN, CRE, CHE, T-CHO, TG, Na, Cl, K, GLU General blood count: WBC, RBC, Hb, Ht, SEG, LYMPH [URINE] labo data (on the registration, two weeks after, and at the end of the study) Specific gravity [OBSERVATION] items Defecation situation (with Bristol scale) Weight and frequency of defecation
- Secondary Outcome Measures
Name Time Method Frequency of abdominal pain, nausea, and vomiting Presence of pressure ulcers, the presence of diaper rash, body weight, catheter problems, and choking